Eli Lilly and Company's monoclonal antibody combination therapy reduced virus levels, hospitalizations and emergency room visits in patients with mild-to-moderate Covid-19, the pharmaceutical company said Wednesday.http://rss.cnn.com/~r/rss/cnn_topstories/~3/u6ih4WV0Brw/index.html" target="_blank">Read More . . .

| | | Tweet